Preparation Of Corona Vaccine: Dry Run In These Four States

Preparation of Corona vaccine: Dry run in these four states including Punjab today and tomorrow.

Although the emergency use of the Corona Virus Vaccine (COVID-19 Vaccine) has not been approved in India, preparation is in the final stages.

In view of this, the first day of the two-day rehearsal is the first day for assessing the vaccination arrangements. This practice is taking place in four states Punjab, Assam, Andhra Pradesh, and Gujarat.

During this time all the processes from the cold chain of the vaccine to the people will be tested. So that the vaccine can be plugged in before delivery.

The co-win prepared for online monitoring of the entire process in practice will also include filling in the required data, deployment of team members, their reporting, and an evening review meeting.

Ministry of Health informed about this. This will also include testing the cold storage and transportation system for the corona vaccine.

The process of ensuring compliance with corona guidelines such as crowd management and physical distance at the vaccination center will also be tested.

During the campaign, practice will be held at five different centers in two districts each of the four states.

These may include district hospitals, community health centers, or primary health centers, urban centers, private hospitals, rural areas.

According to the Ministry of Health, the work of training health workers to carry out the vaccine is going on fast. Training work has been completed in all the states and union territories at the district level.

According to the Ministry of Health, priority groups have been identified for vaccination.

300 million people will be vaccinated during the first phase. In addition to these three crore health workers, security personnel, and scavengers, about 27 crore people above 50 years of age will be included.

It is believed that the Oxford vaccine may be the first to be approved for use. The Serum Institute has submitted additional data on the vaccine’s effect on the drug regulator.